The effect of kharatin oil on improving limb stiffness in patients with neurological disorders

Not Applicable

Recruiting

• Conditions: Spastic hemiplegia; Multiple sclerosis; Condition 1: Tropical spastic paraplegia. Condition 2: Spastic hemiplegia. Condition 3: Multiple sclerosis. Condition 4: Neuromyelitis optica. Condition 5: Hypoxic ischemic encephalopathy. Condition 6: Spondylolysis cervical.; Tropical spastic paraplegia; Neuromyelitis optica [Devic]; Hypoxic ischemic encephalopathy [HIE], unspecified; Spondylolysis, cervical region; G04.1; G81.1; G36.0

• Registration Number: IRCT20210806052093N1
• Lead Sponsor: Kerman University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 30 August 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Existence of spasticity disorder

Exclusion Criteria

Sensitivity to kharatin oil

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Paralysis performance score in modified ashworth scale questionnair. Timepoint: At the beginning of the study and 3 months after starting to use kharatin oil and paraffin. Method of measurement: modified ashworth scale questionnair.

Secondary Outcome Measures

Name	Time	Method
Quality of life score. Timepoint: At the beginning of the study and 3 months after consuming kharatin oil and paraffin. Method of measurement: World Health Organization Quality of Life Questionnaire.